Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Georg Lenz

Showing results (261-270 of 294) with videos related to

Pageof 30
Sort By:
Scientific Reports|February 19, 2026
Trabectedin plus CD13-targeted tissue factor tTF-NGR against advanced relapsed or refractory soft tissue sarcoma: translational data, clinical safety and efficacyKathrin Hessling, Caroline Brand, Christian Schwöppe, et al.
Leukemia|July 1, 2026
Feasibility and safety of rapid glofitamab ramp-upCeline H Liem, Rebecca Wurm-Kuczera, David Böckle, et al.
Nature Medicine|December 24, 2013
Pharmacological and genomic profiling identifies NF-κB-targeted treatment strategies for mantle cell lymphomaRami Rahal, Mareike Frick, Rodrigo Romero, et al.
The New England Journal of Medicine|March 12, 2010
Tumor-associated macrophages and survival in classic Hodgkin's lymphomaChristian Steidl, Tang Lee, Sohrab P Shah, et al.
Blood|March 12, 2020
Coding and noncoding drivers of mantle cell lymphoma identified through exome and genome sequencingPrasath Pararajalingam, Krysta M Coyle, Sarah E Arthur, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 4, 2008
Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathwaysGeorg Lenz, George W Wright, N C Tolga Emre, et al.
Leukemia|July 2, 2025
Induction chemotherapy with CPX-351 in acute myeloid leukemia: revisiting the role of early bone marrow assessmentJulian Ronnacker, Leo Ruhnke, Christoph Röllig, et al.
Nature Genetics|December 24, 2013
Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphomaJessica Okosun, Csaba Bödör, Jun Wang, et al.
Molecular Cancer Therapeutics|October 21, 2020
Selective Vulnerability to Pyrimidine Starvation in Hematologic Malignancies Revealed by AG-636, a Novel Clinical-Stage Inhibitor of Dihydroorotate DehydrogenaseGabrielle McDonald, Victor Chubukov, John Coco, et al.
Nature Communications|July 6, 2022
Clinical relevance of molecular characteristics in Burkitt lymphoma differs according to ageBirgit Burkhardt, Ulf Michgehl, Jonas Rohde, et al.
Pageof 30

Showing results (261-270 of 294) with videos related to

Sort By:
Pageof 30
Scientific Reports|February 19, 2026
Trabectedin plus CD13-targeted tissue factor tTF-NGR against advanced relapsed or refractory soft tissue sarcoma: translational data, clinical safety and efficacyKathrin Hessling, Caroline Brand, Christian Schwöppe, et al.
Leukemia|July 1, 2026
Feasibility and safety of rapid glofitamab ramp-upCeline H Liem, Rebecca Wurm-Kuczera, David Böckle, et al.
Nature Medicine|December 24, 2013
Pharmacological and genomic profiling identifies NF-κB-targeted treatment strategies for mantle cell lymphomaRami Rahal, Mareike Frick, Rodrigo Romero, et al.
The New England Journal of Medicine|March 12, 2010
Tumor-associated macrophages and survival in classic Hodgkin's lymphomaChristian Steidl, Tang Lee, Sohrab P Shah, et al.
Blood|March 12, 2020
Coding and noncoding drivers of mantle cell lymphoma identified through exome and genome sequencingPrasath Pararajalingam, Krysta M Coyle, Sarah E Arthur, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 4, 2008
Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathwaysGeorg Lenz, George W Wright, N C Tolga Emre, et al.
Leukemia|July 2, 2025
Induction chemotherapy with CPX-351 in acute myeloid leukemia: revisiting the role of early bone marrow assessmentJulian Ronnacker, Leo Ruhnke, Christoph Röllig, et al.
Nature Genetics|December 24, 2013
Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphomaJessica Okosun, Csaba Bödör, Jun Wang, et al.
Molecular Cancer Therapeutics|October 21, 2020
Selective Vulnerability to Pyrimidine Starvation in Hematologic Malignancies Revealed by AG-636, a Novel Clinical-Stage Inhibitor of Dihydroorotate DehydrogenaseGabrielle McDonald, Victor Chubukov, John Coco, et al.
Nature Communications|July 6, 2022
Clinical relevance of molecular characteristics in Burkitt lymphoma differs according to ageBirgit Burkhardt, Ulf Michgehl, Jonas Rohde, et al.
Pageof 30